Analysts at Evercore ISI initiated coverage on shares of Tyme Technologies (NASDAQ:TYME) in a report issued on Friday, November 17th. The firm set an “outperform” rating and a $7.00 price target on the stock. Evercore ISI’s target price indicates a potential upside of 79.95% from the stock’s current price.
Tyme Technologies (NASDAQ:TYME) traded up $0.29 during trading hours on Friday, hitting $3.89. The company had a trading volume of 298,794 shares, compared to its average volume of 44,929. Tyme Technologies has a 12 month low of $1.01 and a 12 month high of $9.50.
In other Tyme Technologies news, COO Michael Demurjian sold 50,000 shares of the company’s stock in a transaction that occurred on Tuesday, November 14th. The stock was sold at an average price of $3.34, for a total transaction of $167,000.00. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website.
TRADEMARK VIOLATION NOTICE: “Tyme Technologies (NASDAQ:TYME) Now Covered by Analysts at Evercore ISI” was originally reported by StockNewsTimes and is the property of of StockNewsTimes. If you are reading this piece of content on another site, it was stolen and republished in violation of US & international trademark and copyright law. The original version of this piece of content can be viewed at https://stocknewstimes.com/2017/12/06/tyme-technologies-inc-tyme-coverage-initiated-by-analysts-at-evercore-isi.html.
Tyme Technologies, Inc is a clinical-stage biotechnology company. The Company is focused on developing cancer therapeutics that is intended to be broadly effective across tumor types and have low toxicity profiles. The Company’s therapeutic approach is designed to take advantage of a cancer cell’s innate metabolic weaknesses to compromise its defenses, leading to cell death through oxidative stress and exposure to the body’s natural immune system.
Receive News & Ratings for Tyme Technologies Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tyme Technologies Inc. and related companies with MarketBeat.com's FREE daily email newsletter.